about
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products include INKmune,...
Read More
1.50
0.03
(2.04%)
235.0K
XNAS Volume
XNAS 13 Jan, 2026 4:02 PM (EST)
Not Eligible
Expensive Valuation
Technically Bearish
INmune Bio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..